Which medication administered to a person with diabetes can cause severe hypoglycemia if given in excess?

Insulin and Sulfonylureas Cause Severe Hypoglycemia in Diabetic Patients

Insulin and sulfonylureas are the two primary diabetes medications that can cause severe, life-threatening hypoglycemia when given in excess, with insulin overdose being particularly dangerous and capable of causing prolonged critical illness. 1, 2

Primary Culprit Medications

Insulin

• Most dangerous when overdosed, causing profound and potentially fatal hypoglycemia 3, 4
• Long-acting insulin (glargine) at doses exceeding 0.9 IU/kg can cause prolonged hypoglycemia lasting several days 3
• Even massive oral ingestion (3000 units) can cause symptomatic hypoglycemia despite poor bioavailability 5
• Overdoses often require days of IV glucose, with risks of thrombophlebitis, fluid overload, and glycogenic hepatopathy 3

Sulfonylureas

• Second major class causing severe hypoglycemia 1, 2
• Explicitly identified in guidelines as high-hypoglycemia-risk medications requiring deintensification consideration 2
• Meglitinides carry similar risks 2

Clinical Recognition and Management Algorithm

When evaluating a diabetic patient who is severely ill from medication:

1. Check blood glucose immediately - hypoglycemia (<70 mg/dL) confirms the diagnosis 2

2. For conscious patients with hypoglycemia:

   • Give 15 grams of glucose orally 2
   • Recheck in 15 minutes; repeat treatment if hypoglycemia persists 2

3. For severe/refractory hypoglycemia:

   • IV dextrose infusion is first-line 3, 4
   • Glucagon preparations not requiring reconstitution are strongly recommended over those requiring reconstitution 1
   • Consider adjunctive corticosteroids (hydrocortisone) early for refractory cases to prevent volume overload from massive dextrose requirements 3, 4
   • Octreotide may be used, particularly for sulfonylurea overdose 4

Important Caveats

Metformin does NOT typically cause hypoglycemia in therapeutic doses, as it doesn't induce insulin release. However, massive overdoses (>60g) can paradoxically cause severe hypoglycemia with concurrent hypothermia and lactic acidosis 6. This is rare and represents an exception to metformin's usual safety profile.

The altered pharmacokinetics of insulin glargine make subcutaneous overdoses particularly problematic, requiring prolonged monitoring and treatment 3. Interestingly, intravenous insulin glargine overdose may resolve more quickly and require only 6 hours observation 7, though subcutaneous overdoses demand days of management.

Prevention Strategy

Guidelines strongly recommend:

• Real-time continuous glucose monitoring (CGM) for all individuals at high risk for hypoglycemia 1, 2
• Regular screening for impaired hypoglycemia awareness 2
• Deintensification of insulin, sulfonylureas, or meglitinides when hypoglycemia risk exceeds benefit 2
• Switching to lower-risk agents (SGLT2 inhibitors, GLP-1 receptor agonists) when appropriate 2